XPC and esophageal squamous cell carcinoma: We observed that XPA was amplified in 8 ESCC patients (5.2%) and deleted in 2 ESCC cases (1.3%), whereas the incidences of amplification and deletion of XPC were 1.3% (2/154) and 5.2% (8/154), respectively.